Image Fusion of SPECT MPI and Fluoroscopy Venography to Guide LV Lead Placement for Improved CRT Response (GUIDE-CRT II)

NCT03125720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-08-17

No results posted yet for this study

Summary

CRT response will be significantly better using image fusion of SPECT MPI and fluoroscopy venogram to guide LV lead placement at the latest activation segment without scar than standard-of-care implantation.

Conditions

Interventions

OTHER

Image fusion of SPECT MPI and fluoroscopy venography

In this study, MPI-Fluoro Fusion tool is used to help the implanting physicians to precisely implant LV lead to the optimal/suboptimal venous segments in the guided group.

Sponsors & Collaborators

  • Fu Wai Hospital, Beijing, China

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Shanghai Chest Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Xijing Hospital

    collaborator OTHER
  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER
  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • First People's Hospital of Hangzhou

    collaborator OTHER
  • Anhui Provincial Hospital

    collaborator OTHER_GOV
  • The Affiliated Hospital of Xuzhou Medical University

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Dalian Medical University

    collaborator OTHER
  • General Hospital of Shenyang Military Region

    collaborator OTHER
  • Nanjing Medical University

    collaborator OTHER
  • Subei People's Hospital of Jiangsu Province

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Jiangang Zou, MD,Ph.D · The First Affiliated Hospital with Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-14
Primary Completion
2024-12-31
Completion
2025-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03125720 on ClinicalTrials.gov